Package Insert: Information for the User
Atoris30mg Film-Coated Tablets
atorvastatina
Read this package insert carefully before starting to take this medicine, as it contains important information for you.
Atoris belongs to a group of medications known as statins, which are the medications that regulate lipids (fats).
Atoris is used to reduce the lipids called cholesterol and triglycerides in the blood when a low-fat diet and lifestyle changes have not been sufficient. If you have a high risk of heart disease, Atoris may also be used to reduce this risk even if your cholesterol levels are normal. During treatment, a standard low-cholesterol diet must be followed.
Do not take Atoris
Warnings and precautions
Consult your doctor or pharmacist before starting to take Atoris.
For the following reasons, Atoris may not be suitable for you:
In any of these cases, your doctor may instruct you to have blood tests before and possibly during treatment with Atoris to predict the risk of adverse effects related to muscle. It is known that the risk of adverse effects related to muscle (e.g. rhabdomyolysis) increases when certain medications are taken at the same time (see section 2 “Other medications and Atoris”).
Also inform your doctor or pharmacist if you experience persistent muscle weakness. Additional tests and medications may be necessary to diagnose and treat this problem.
While taking this medication, your doctor will monitor if you have diabetes or risk of developing diabetes. This risk of diabetes increases if you have high blood sugar and lipid levels, overweight, and high blood pressure.
Other medications and Atoris
There are some medications that may affect the proper functioning of Atoris or the effects of these medications may be modified by Atoris. This type of interaction may reduce the effect of one or both medications. Alternatively, this concomitant use may increase the risk or severity of adverse effects, including the important muscle deterioration, known as rhabdomyolysis described in section 4:
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.
Taking Atoris with food, drinks, and alcohol
See section 3 for instructions on how to take Atoris. Please note the following:
Orange juice
Do not take more than one or two small glasses of orange juice per day, as large amounts of orange juice may alter the effects of Atoris.
Alcohol
Avoid drinking large amounts of alcohol while taking this medication. See details in section 2 “Warnings and precautions”
Pregnancy and breastfeeding
Do not take Atoris if you are pregnant, think you may be pregnant, or are trying to become pregnant.
Do not take Atoris if you are fertile and do not use adequate contraceptive measures.
Do not take Atoris if you are breastfeeding your child.
The safety of Atoris during pregnancy and breastfeeding has not been demonstrated. Consult your doctor or pharmacist before starting to take this medication.
Driving and operating machinery
Normally, this medication does not affect your ability to drive or operate machinery. However, do not drive if this medication affects your ability to drive. Do not operate tools or machinery if your ability to operate them is affected by this medication.
Atoris contains lactose and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medication.
This medication contains less than 1 mmol per dose unit (23 mg); that is, it is essentially "sodium-free".
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Before starting treatment, your doctor will put you on a low-cholesterol diet, which you must also follow during treatment with Atoris.
The initial recommended dose ofatorvastatinais 10 mg once a day in adults and children aged 10 years and above. Your doctor may increase it if necessary to reach the dose you need. Your doctor will adjust the dose at intervals of 4 weeks or more. The maximum dose of Atoris is 80 mg once a day for adults and 20 mg once a day for children.
Atoris tablets should be swallowed whole with a glass of water and can be taken at any time of the day with or without food. However, try to take your tablet every day at the same time.
Your doctor will decide the duration of treatment withAtoris.
Ask your doctor if you think the effect ofAtorisis too strong or too weak.
If you take more Atoris than you should
If you accidentally take too many tablets ofAtoris (more than your usual daily dose),consult your doctor or the nearest hospital.In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to take Atoris
If you forgot to take a dose, take the next scheduled dose at the correct time. Do not take a double dose to compensate for the missed doses.
If you have any other questions about the use of this medication or wish to discontinue treatment, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you notice any of the following serious side effects or symptoms, stop taking these tablets and inform your doctor immediately or visit the nearest hospital emergency service.
Rare (can affect up to 1 in 1,000 people):
Very rare (can affect up to 1 in 10,000 people):
Other possible side effects with Atoris:
Frequent side effects (can affect up to 1 in 10 people) include:
Infrequent side effects (can affect up to 1 in 100 people) include:
Rare side effects (can affect up to 1 in 1,000 people) include:
Very rare side effects (can affect up to 1 in 10,000 people) include:
Frequency not known (cannot be estimated from available data):
Consult your doctor if you experience weakness in the arms or legs that worsens after periods of activity, double vision, eyelid drooping, difficulty swallowing, or difficulty breathing.
Possible side effects of some statins (medicines of the same type):
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:http://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from moisture.
This medication does not require any special storage temperature.
Medications should not be disposed of through drains or trash. Dispose of packaging and medications you no longer need at the SIGRE drop-off point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Composition of Atoris
Each film-coated tablet contains 30 mg of atorvastatina as atorvastatina calcium.
Appearance of the product and contents of the package
The 30 mg tablets are white or almost white, round, slightly convex, film-coated tablets with a beveled edge, and a tablet diameter of 9 mm.
Available in boxes of 4, 7, 10, 14, 20, 28, 30, 50, 56, 60, 84, 90, 98, and 100 film-coated tablets.
Only some package sizes may be marketed.
Marketing Authorization Holder
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Responsible for manufacturing
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia.
TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany.
For more information about this medicine, please contact the local representative of the marketing authorization holder:
KRKA Farmacéutica, S.L., C/ Anabel Segura 10, Pta. Baja, Oficina 1, 28108 Alcobendas, Madrid, Spain
This medicine is authorized in the member states of the European Economic Area with the following names:
Member state name | Medicine name |
Spain | Atoris |
Portugal | Atorvastatina Krka |
Sweden | Atostin |
Germany | Atostin |
Last review date of this leaflet:January 2025
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/).
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.